McIlroy backs PGA Tour drug testing reforms


  • Golf
  • Thursday, 22 Jun 2017

Jun 16, 2017; Erin, WI, USA; Rory McIlroy plays his shot from the 13th tee during the second round of the U.S. Open golf tournament at Erin Hills. Michael Madrid-USA TODAY Sports

(Reuters) - Four-time major winner Rory McIlroy has voiced support for the PGA Tour's drug-testing reforms that introduce blood screening and revise the list of banned substances to match the World Anti-Doping Agency's directory for the 2017-18 season.

Last July, the 28-year-old Briton expressed concern over the lack of regular drug testing in golf compared with other Olympic sports and advocated the introduction of blood testing.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Golf

Mirabel looks forward to fun week in her second Arnold Palmer Cup outing
Golf-Troon's sixth hole to set Open distance record
Golf-Olympics on Green's mind after second LPGA win of the season
Golf-Bradley impressed but not intimidated by Scheffler's dominance
Bubbly Jing Xuen misses home and can’t wait to play in KL Open
How to hit pure iron shots
New look SpeedSoft golf ball launched
Golfest returns, bigger and better
Superlative Scheffler and Korda
Regional retailer opens third outlet in Indonesia

Others Also Read